CLARIFICATION

The trial that was recently terminated by RNSH had NOTHING to do with DARRT.

1. The RNSH trial was an Investigator Sponsored trial, completely out of the control of Noxopharm
2. The RNSH trial protocol had inclusion criteria that was almost impossible to find in end-stage patients
3. It took an inordinately long time for everything to get organised – at least 18 months IIRC
4. Meanwhile, Noxopharm approached the TROG group and they organised the first DARRT trial
5. This trial was fully recruited before RNSH was ready to proceed
6. The RNSH trial in effect became a copy of a study that Noxopharm had already completed, and was redundant.

This is a storm in a teacup that caused some shareholders to question whether DARRT was in trouble.

I repeat: the DARRT trial HAS NOT BEEN CANCELLED.